Ventilation Distribution in COPD Patients During Breathing Exercises
Launched by WILLIAM PONCIN, PT, PHD · Apr 23, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a breathing technique called ELTGOL, which is designed to help people with Chronic Obstructive Pulmonary Disease (COPD) improve airflow in their lungs while lying on their side. The researchers want to see how well this technique works in both COPD patients and healthy individuals, and how the use of gentle pressure on the chest and abdomen may affect the way air moves through the lungs during the exercises.
To participate in this study, healthy volunteers should have normal lung function and no history of respiratory diseases, while COPD patients must have a specific level of lung function and be in stable condition. Participants can expect to undergo breathing exercises and possibly receive manual pressure during the sessions. This trial is currently recruiting participants of all genders and ages over 18, and it aims to gather valuable information that could help improve care for people with COPD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy subjects: No acute or chronic respiratory disease, normal lung function, non-smoker.
- • Patients with COPD: forced expiratory volume at one second (FEV1) ≤ 80% predicted value, in stable state.
- Exclusion Criteria:
- • Healthy subjects: obesity (BMI \> 35kg/m²); active or former smoker; severe scoliosis; cardiovascular or neuromuscular disease; active implant (cardiac pacemaker or an implantable cardioverter-defibrillator (ICD); thoracic skin lesion.
- • Patients with COPD: obesity (BMI \> 35kg/m²); severe scoliosis; severe cardiovascular disease; neuromuscular disease; active implant (cardiac pacemaker or an implantable cardioverter-defibrillator (ICD); thoracic skin lesion.
About William Poncin, Pt, Phd
Dr. William Poncin, PT, PhD, is a distinguished clinical trial sponsor with extensive expertise in physical therapy and rehabilitation sciences. With a robust academic background and a commitment to advancing evidence-based practices, Dr. Poncin leads innovative research initiatives aimed at improving patient outcomes. His work is characterized by a rigorous methodological approach and a dedication to translating clinical findings into practical applications. Dr. Poncin’s leadership in clinical trials reflects a deep understanding of both the scientific and therapeutic dimensions of healthcare, making him a valuable asset to the research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, Brussels Capital, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported